❌

Reading view

The Path Matters: Learning a Token-Commitment Policy for Diffusion Language Models

arXiv:2605.24697v1 Announce Type: cross Abstract: Diffusion large language models promise faster generation by refining many token positions in parallel, but this parallelism introduces a hidden control problem: which proposed tokens should be transferred into the partially decoded sequence at each step? We refer to this decision as token commitment. Existing frozen-generator decoders largely rely on hand-designed confidence rules or block-specific acceptance filters. We argue that token commitment can instead be learned as a reusable trace-state policy. We introduce TraceLock, a lightweight plug-in controller that instantiates this policy for a frozen diffusion language model. Since oracle commitment times are unavailable, TraceLock derives self-supervision from future stability: at decoding step t, a proposed token for position i is labeled stable if it matches the final token at position i after the full decoding trace completes. The controller scores variable-length trace states and decides which active token proposals should be committed to the partially decoded sequence. Once trained for a given frozen backbone, the controller can be deployed across local-window widths, generation lengths, and step budgets without retraining or per-setting calibration. Experiments on question answering, mathematical reasoning, and code generation show that TraceLock improves the quality-step tradeoff over heuristic and learned baselines, with particularly stable behavior under cross-setting deployment. Diagnostic analyses show that its decisions are not reducible to scalar confidence, suggesting that frozen diffusion language models expose a learnable space of commitment trajectories beyond confidence-based decoding. Code is available at https://github.com/BobSun98/TraceLock.
  •  

Pulmonary-Intestinal Axis: Shared Genetic Basis and Mediating Factors Identified Through Multi-Omics Analysis

Int J Chron Obstruct Pulmon Dis. 2026 Apr 7;21:561645. doi: 10.2147/COPD.S561645. eCollection 2026.

ABSTRACT

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a systemic condition with comorbidities beyond the lung (eg, cardiovascular and metabolic disorders), and gastrointestinal (GI) disorders are also common. The shared genetic basis of COPD-GI comorbidity and its mediating factors remain unclear. We hypothesized that COPD and GI diseases share pleiotropic genetic architecture implicating lipid-metabolic pathways, with smoking mediating part of the association.

METHODS: We analyzed publicly available European-ancestry GWAS summary statistics for COPD (Global Biobank Meta-analysis Initiative), 15 GI diseases (FinnGen), and smoking phenotypes (UK Biobank). Genetic correlation was estimated using linkage disequilibrium score regression (LDSC) and high-definition likelihood (HDL). Multi-trait analysis of GWAS (MTAG) boosted COPD discovery by leveraging genetically correlated GI traits. We integrated locus-to-gene mapping with multi-tissue expression quantitative trait loci (eQTL) and plasma protein quantitative trait loci (pQTL) evidence to prioritize shared loci, genes, and proteins. Bidirectional two-sample Mendelian randomization (MR) tested causal directions, and two-step mediation MR evaluated smoking.

RESULTS: COPD showed significant genetic correlation with nine GI diseases. We identified six comorbidity-associated loci (three with CADD > 12.37) and 13 unique candidate pleiotropic genes; APOE was supported by proteomic evidence. Enrichment analyses highlighted lipid-metabolism pathways. MR suggested COPD increases risk of gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), acute appendicitis, and gastric ulcer, while diverticular disease showed reverse causality toward COPD. Smoking partially mediated the COPD effect on GERD, acute appendicitis, and gastric ulcer.

CONCLUSION: COPD and multiple GI disorders share a distributed pleiotropic genetic basis within the broader systemic comorbidity spectrum of COPD. Multi-omics evidence supports a genomic pulmonary-intestinal axis in which lipid metabolism and smoking-related mechanisms contribute to COPD and GI comorbidity, providing targets for risk stratification and potential intervention.

PMID:41978582 | PMC:PMC13070119 | DOI:10.2147/COPD.S561645

  •  
❌